866-997-4948(US-Canada Toll Free)

Nanotechnology Drug Delivery Market (By Technology - Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; By Application - Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Published By :

Transparency Market Research

Published Date : Mar 2016

Category :

Nanotechnology

No. of Pages : 120 Pages

Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e. nano-technology), resulting in a number of products, including therapeutics and imaging agents, enabling more effective and less toxic therapeutic and diagnostic interventions. This progress have resulted in development of innovative diagnostic and therapeutic personalized nano-medicine treatment. Rapidly expanding areas of research and development to develop novel nano-medicine is expected to drive the market growth in future. Moreover, one of the major factor assisting market growth is the rising prevalence of infectious diseases and cancer, developing nanotechnology research, and rising demand for novel drug delivery systems. However, high cost coupled with stringent regulatory scenario hampers the market growth to some extent. 

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global nanotechnology drug delivery market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, technology trend, industry challenges, sale data for some non-marketed nano-pharmaceuticals, patent landscape, and market share analysis by key players (%) operating in the nanotechnology drug delivery market. 

Based on technology, the global nanotechnology drug delivery market has been segmented into nanocrystals, nanoparticles, liposomes, micelles, nanotubes and others. The market for these technology types has been extensively analyzed based on sales revenue of the various leading marketed products developed by the manufacturers. The market size and forecast in terms of USD million for each technology has been provided for the period from 2013 to 2023. The report on the nanotechnology drug delivery market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year. 

Additionally, the report also categorized based on different application area of nanotechnology such as neurology, oncology, cardiovascular/physiology, anti-inflammatory/immunology, anti-infective and other applications. The market size and forecast in terms of USD million for each application has been provided for the period from 2013 to 2023. The report also provides compound annual growth rate (CAGR %) for each application segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year. 

Geographically, the global nanotechnology drug delivery market has been categorized into North America, Europe, Asia-Pacific, Latin America and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2013 to 2023 along with CAGR (%) for the forecast period from 2013 to 2023. The research study also incorporates the competitive scenario of major players in these regions. 

The report concludes with the profiles of major players in the global nanotechnology drug delivery market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc and others.

The global nanotechnology drug delivery market is segmented as follows:

Global Nanotechnology Drug Delivery Market, by Technology

  • Nanocrystals
  • Nanoparticles
  • Dendrimers
  • Gold Nanopartilces
  • Dendrimers
  • Fullerens
  • Others
  • Liposomes
  • Micelles
  • Nanotubes
  • Others

Global Nanotechnology Drug Delivery Market, by Applications

  • Neurology
  • Oncology
  • Cardiovascular/Physiology
  • Anti-inflammatory/Immunology
  • Anti-infective
  • Other Applications

Global Nanotechnology Drug Delivery Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Rest of the World (RoW)

Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Nanotechnology Drug Delivery Market 
2.2 Nanotechnology based Drug Delivery (Historical Development)
2.3 Industrial Prospective
2.4 Global Nanotechnology Drug Delivery Market Share, by Geography, 2014 & 2023 (Value %)
2.5 Global Nanotechnology Drug Delivery Market Share, by Technology, 2014 (Value %)
2.6 Global Nanotechnology Drug Delivery Market Share, by Application, 2014 (Value %)

Chapter 3 Market Overview
3.1 Introduction
3.1.1 Market Definition
3.1.1.1 Industry Overview
3.1.1.2 Global Nanotechnology Drug Delivery MarketShare
3.1.1.3 Technology Trends
3.1.2 Industry Challenges
3.1.3 Sales Data for Some Marketed Nano-Pharmaceuticals
3.1.4 Investigational Nano-Pharmaceuticals
3.1.5 Patent Landscape
3.2 Market Dynamics
3.3 Porter’s Five Forces Analysis
3.4 Market Attractiveness Analysis - Global Nanotechnology Drug Delivery Market
3.5 Global Nanotechnology Drug Delivery Market, by Key Players, 2014 (%)

Chapter 4 Nanotechnology Drug Delivery Market, by Technology
4.1 Introduction
4.1.1 Nanotechnology Drug Delivery Market Revenue, by Technology, 2013–2023 (US$ Mn)
4.2 Nanocrystals
4.2.1 Global Nanocrystals Market Revenue, 2013–2023 (US$ Mn)
4.3 Nanoparticles
4.3.1 Global Nanoparticles Market Revenue, 2013–2023 (US$ Mn)
4.3.2.1 Dendrimers
4.3.2.1 Global Dendrimers Market Revenue, 2013–2023 (US$ Mn)
4.3.3 Gold Nanopartilces
4.3.3.1 Global Gold Nanoparticles Market Revenue, 2013–2023 (US$ Mn)
4.3.4 Fullerens
4.3.4.1 Global Fullerens Market Revenue, 2013–2023 (US$ Mn)
4.3.5 Other Nanoparticle Market Revenue, 2013-2023 (US$ Mn)
4.4 Liposomes
4.4.1 Global Liposomes Market Revenue, 2013–2023 (US$ Mn)
4.5 Micelles
4.5.1 Global Micelles Market Revenue, 2013–2023 (US$ Mn)
4.6 Nanotubes 
4.6.1 Global Nanotubes Market Revenue, 2013–2023 (US$ Mn)
4.7 Others
4.7.1 Global Others Market Revenue, 2013–2023 (US$ Mn)

Chapter 5 Applications
5.1 Introduction
5.1.1 Global Nanotechnology Drug Delivery Market Revenue, by Application, 2013–2023 (US$ Mn)
5.2 Neurology
5.2.1 Global Neurology Market Revenue, 2013–2023 (US$ Mn)
5.3 Oncology
5.3.1 Global Oncology Market Revenue, 2013–2023 (US$ Mn)
5.4 Cardiovascular/Physiology
5.4.1 Global Cardiovascular Market Revenue, 2013–2023 (US$ Mn)
5.5 Anti-inflammatory/Immunology
5.5.1 Global Anti-inflammatory Market Revenue, 2013–2023 (US$ Mn)
5.6 Anti-infective
5.6.1 Global Anti-infective Market Revenue, 2013–2023 (US$ Mn)
5.7 Other Applications
5.7.1 Global Other Applications Market Revenue, 2013–2023 (US$ Mn)

Chapter 6 Geography
6.1 Introduction
6.1.1 Global Nanotechnology Drug delivery Market Revenue, by Geography, 2013–2023 (US$ Mn)
6.2 North America
6.2.1 North America Nanotechnology Drug delivery Market Revenue, by Country, 2013–2023 (US$ Mn)
6.3 Europe
6.3.1 Europe Nanotechnology Drug Delivery Market Revenue, by Country, 2013–2023 (US$ Mn)
6.4 Asia Pacific
6.4.1 Asia Pacific Nanotechnology Drug Delivery Market Revenue, by Country, 2013–2023 (US$ Mn)
6.5 Latin America
6.5.1 Latin America Nanotechnology Drug Delivery Market Revenue, by Country, 2013–2023 (US$ Mn)
6.7 Rest of the World
6.7.1 Rest of the World Nanotechnology Drug Delivery Market Revenue, 2013–2023 (US$ Mn)

Chapter 7 Company Profiles
7.1 AbbVie, Inc.
7.2 Amgen Inc.
7.3 Celgene Corporation 
7.4 Johnson & Johnson 
7.5 Merck & Co., Inc.
7.6 Novartis International AG
7.7 Perrigo Company plc
7.8 Pfizer, Inc.
7.9 Teva Pharmaceutical Industries Ltd.

List of Table

TABLE 1 Market Snapshot: Global Nanotechnology Drug Delivery Market
TABLE 2 Sales Data for some Marketed Nano Pharmaceuticals
TABLE 3 Investigational Nano Pharmaceuticals
TABLE 4 Patent Landscape
TABLE 5 Global Nanotechnology Drug Delivery Market Revenue, by Technology, 2013 – 2023 (US$ Mn)
TABLE 6 Global Nanoparticle Market Revenue, by Types, 2013 – 2023 (US$ Mn)
TABLE 7 Global Nanotechnology Drug Delivery Market Revenue, by Application, 2013 – 2023 (US$ Mn)
TABLE 8 Global Nanotechnology Drug Delivery Market Revenue, by Geography, 2013 – 2023 (US$ Mn)
TABLE 9 North America Nanotechnology Drug Delivery Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 10 Europe Nanotechnology Drug Delivery Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 11 Asia Pacific Nanotechnology Drug Delivery Market Revenue, by Country, 2013 – 2023 (US$ Mn)
TABLE 12 Latin America Nanotechnology Drug Delivery Market Revenue, by Country, 2013 – 2023 (US$ Mn)

List of Chart

FIGURE 1 Market Segmentation: Nanotechnology Drug Delivery Market
FIGURE 2 Global Nanotechnology Drug Delivery Market Share, by Geography 2014 and 2023 (Value %)
FIGURE 3 Global Nanotechnology Drug Delivery Market, by Technology, 2014
FIGURE 4 Global Nanotechnology Drug Delivery Market, by Application, 2014
FIGURE 5 Patent Filing for Nanoparticles, 2000 – 2014
FIGURE 6 Patent Filing for Major Nanotechnology Drug Delivery Platforms, 2000 – 2014
FIGURE 7 Porters Five Forces Analysis: Global Nanotechnology Drug Delivery Market
FIGURE 8 Global Nanotechnology Drug Delivery Market, by Geography, 2014
FIGURE 9 Global Nanotechnology Drug Delivery Market Share, by Key Players, 2013 (%)
FIGURE 10 Global Nanotechnology Drug Delivery Market Share, by Key Players, 2014 (%)
FIGURE 11 Global Nanocrystals Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 12 Global Dendrimers Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 13 Global Gold Nanoparticles Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 14 Global Fullerenes Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 15 Global Other Nanoparticles Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 16 Global Liposomes Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 17 Global Micelles Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 18 Global Nanotubes Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 19 Global Other Nanotechnology Drug Delivery Platforms Technology Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 20 Global Neurology Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 21 Global Oncology Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 22 Global Cardiovascular/Physiology Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 23 Global Anti-inflammatory/Immunology Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 24 Global Anti-infective Application Revenue, 2013 – 2023 (US$ Mn)
FIGURE 25 Global Others Application Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 26 U.S. Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 27 Canada Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 28 U.K. Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 29 Germany Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 30 Rest of Europe Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 31 China Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 32 Japan Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 33 Rest of Asia Pacific Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 34 Brazil Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 35 Mexico Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 36 Rest of World Nanotechnology Drug Delivery Market Revenue, 2013 – 2023 (US$ Mn)
FIGURE 37 AbbVie, Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 38 Amgen, Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 39 Celgene Corporation: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 40 Johnson & Johnson: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 41 Merck & Co., Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 42 Novartis International AG: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 43 Perrigo Company plc: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 44 Pfizer, Inc.: Financial Overview, 2012 – 2014 (US$ Mn)
FIGURE 45 Teva Pharmaceuticals Industries, Ltd.: Financial Overview, 2012 – 2014 (US$ Mn)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *